Dachaigh › Schizophrenia › Illinois
Sgrùdaidhean clionaigeach Schizophrenia ann an Illinois
Tha 26 sgrùdaidhean airson Schizophrenia a’ lorg phàirtichean aig làraichean ann an Illinois.
Bailtean ann an Illinois
Teacsa sgrùdaidh oifigeil (Beurla)
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- The University of Chicago, Chicago
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07853807Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Evanston Hospital, Evanston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Uptown Research Institute, Chicago
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Baber Research Group, Naperville
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Chicago
- Neurocrine Clinical Site, Oak Brook
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07114874A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0175, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Re:Cognition Health - Chicago, Chicago
A’ fastadhÌre 2
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT0710511152-week Open Label Safety-Tolerability Study
- Pillar Clinical Research, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0122, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A’ fastadhÌre 3
Aoisean 13 gu 17 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Uptown Research Institute, Chicago
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Chicago
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0046, Crystal Lake
- Amr Conventions Research - Illinois, Warrenville
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Chicago
A’ fastadhÌre 3
Aoisean 10 gu 17 · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT05303064Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Pillar Clinical Research, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07363577Transition Care for FEP
- University of Chicago Ingalls Memorial Hospital, Harvey
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 40 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07713849A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Uptown Research Institute, Chicago
A’ fastadhÌre 2
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT07221877CLOZAPINE Response in Biotype-1
- University of Chicago, Chicago
A’ fastadhÌre 4
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT04580134Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 40 · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 6 Màrt 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Chicago
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5056, Chicago
A’ fastadhÌre 2
Aoisean 21 gu 55 · Gach gnè · Air ùrachadh 26 Dùbh 2025 · NCT06502964Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Chicago
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 19 Dùbh 2024 · NCT05184335Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.